Role of retinal mitochondria in the development of diabetic retinopathy

References

• Grassi G. Diabetic retinopathy. Minerva Med.94, 419–435 (2003).
   PubMedGoogle Scholar
• de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom. Med.63, 619–630 (2001).
   PubMed Web of Science ®Google Scholar
• Sharma S, Oliver-Fernandez A, Liu W, Buchholz P, Walt J. The impact of diabetic retinopathy on health-related quality of life. Curr. Opin. Ophthalmol.16, 155–159 (2005).
   PubMedGoogle Scholar
• Engerman RL, Kern TS. Hyperglycemia as a cause of diabetic retinopathy. Metabolism35(Suppl. 1), 20–23 (1986).
   PubMed Web of Science ®Google Scholar
• Aiello LP, Gardner TW, King GL et al. Diabetic retinopathy. Diabetes Care21, 143–156 (1998).
   PubMed Web of Science ®Google Scholar
• Frank RN. Diabetic Retinopathy. N. Engl. J. Med.350, 48–58 (2004).
   PubMed Web of Science ®Google Scholar
• Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin. Invest.97, 2883–2890 (1996).
   PubMed Web of Science ®Google Scholar
• Kern TS, Tang J, Mizutani M, Kowluru R, Nagraj R, Lorenzi M. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest. Ophthalmol. Vis. Sci.41, 3972–3978 (2000).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Odenbach S. Effect of long-term administration of α lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes53, 3233–3238 (2004).
   PubMed Web of Science ®Google Scholar
• Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes47, 455–459 (1998).
   Google Scholar
• Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest.102, 783–791 (1998).
   PubMed Web of Science ®Google Scholar
• de Venecia G, Davis MD, Engerman RL. Clinicopathologic correlations in diabetic retinopathy. 1. Histology and fluorescein angiography of microaneurysms. Arch. Ophthalmol.94, 1766–1773 (1976).
   PubMedGoogle Scholar
• Schröder S, Palinski W, Schmid-Schönbein GW. Activated monocyte and granulocytes, capillary nonperfusion and neovascularization in diabetic retinopathy. Am. J. Pathol.139, 81–100 (1991).
   PubMed Web of Science ®Google Scholar
• Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med.329, 977–986 (1993).
   PubMed Web of Science ®Google Scholar
• United Kingdom Prospective Diabetes Study. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet352, 837–853 (1998).
   PubMed Web of Science ®Google Scholar
• Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL. Characterization of the mechanism for the chronic activation of DAG–PKC pathway in diabetes and hypergalactosemia. Diabetes43, 1122–1129 (1994).
   PubMed Web of Science ®Google Scholar
• Sun W, Oates PJ, Coutcher JB, Gerhardinger C, Lorenzi M. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes55, 2757–2762 (2006).
   PubMed Web of Science ®Google Scholar
• Baynes JW, Thrope SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes48, 1–9 (1999).
   PubMed Web of Science ®Google Scholar
• Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp. Mol. Pathol.75, 95–108 (2003).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes50, 1938–1942 (2001).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kennedy A. Therapeutic potential of anti-oxidants and diabetic retinopathy. Expert Opin. Invest. Drugs10, 1665–1676 (2001).
   PubMed Web of Science ®Google Scholar
• Miwa K, Nakamura J, Hamada Y et al. The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res. Clin. Pract.60, 1–9 (2003).
   PubMed Web of Science ®Google Scholar
• Kowluru RA. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are inter-related. Acta Diabetologica38, 179–185 (2001).
   PubMed Web of Science ®Google Scholar
• Wu Y, Wu G, Qi X et al. Protein kinase C β inhibitor LY333531 attenuates intercellular adhesion molecule-1 and monocyte chemotactic protein-1 expression in the kidney in diabetic rats. J. Pharmacol. Sci.101, 335–343 (2006).
   PubMed Web of Science ®Google Scholar
• Aiello LP, Wong JS. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int.77, S113–S119 (2000).
   Google Scholar
• Lu M, Kuroki M, Amano S et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J. Clin. Invest.101, 1219–1224 (1998).
   PubMed Web of Science ®Google Scholar
• Aiello LP, Brusell SE, Clermont A et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β isoform-selective inhibitor. Diabetes46, 1473–1480 (1997).
   PubMed Web of Science ®Google Scholar
• DeBosch BJ, Baur E, Deo BK, Hiraoka M, Kumagai AK. Effects of insulin-like growth 5 factor-1 on retinal endothelial cell glucose transport and proliferation. J. Neurochem.77, 1157–1167 (2001).
   PubMed Web of Science ®Google Scholar
• Haskins K, Bradley B, Powers K et al. Oxidative stress in Type 1 diabetes. Ann. NY Acad. Sci.1005, 43–54 (2003).
   PubMed Web of Science ®Google Scholar
• Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature414, 813–820 (2001).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Rad. Biol. Med.22, 587–592 (1996).
   Web of Science ®Google Scholar
• Heath H, Rutter AC, Beck TC. Changes in the ascorbic acid and glutathione content of the retinae and adrenals from alloxan-diabetic rats. Vision Res.2, 431–437 (1962).
   Web of Science ®Google Scholar
• Du Y, Miller CM, Kern TS. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Rad. Biol. Med.35, 1491–1499 (2003).
   PubMed Web of Science ®Google Scholar
• Ellis EA, Guberski DL, Somogyi-Mann M et al. Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Rad. Biol. Med.28, 91–101 (2000).
   PubMed Web of Science ®Google Scholar
• Li W, Yanoff M, Jian B, He Z. Altered mRNA levels of antioxidant enzymes in preapoptotic pericytes from human diabetic retinas. Cell Mol. Biol.45, 59–66 (1999).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Koppolu P. Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Rad. Res.36, 993–999 (2002).
   PubMed Web of Science ®Google Scholar
• Colantuoni A, Longoni B, Marchiafava PL. Retinal photoreceptors of Syrian hamsters undergo oxidative stress during streptozotocin-induced diabetes. Diabetologia45, 121–124 (2002).
   PubMed Web of Science ®Google Scholar
• Li JM, Shah AM. Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology. Am. J. Physiol. Regul. Integr. Comp. Physiol.287, 1014–1030 (2004).
   PubMed Web of Science ®Google Scholar
• Young TA, Cunningham CC, Bailey SM. Reactive oxygen species production by the mitochondrial respiratory chain in isolated rat hepatocytes and liver mitochondria: studies using myxothiazol. Arch. Biochem. Biophys.405, 65–72 (2002).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kowluru A, Kanwar M. Small molecular weight G-protein, H-Ras, and retinal endothelial cell apoptosis in diabetes. Mol. Cell. Biochem.296, 69–76 (2007).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kowluru V, Ho YS, Xiong Y. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Rad. Biol. Med.41, 1191–1196 (2006).
   PubMed Web of Science ®Google Scholar
• Murphy MP. Nitric oxide and cell death. Biochim. Biophys. Acta1411, 401–414 (1999).
   PubMed Web of Science ®Google Scholar
• Costa NJ, Dahm CC, Hurrell F, Taylor ER, Murphy MP. Interactions of mitochondrial thiols with nitric oxide. Antioxid. Redox Signal.5, 291–305 (2003).
   PubMed Web of Science ®Google Scholar
• Bergamini CM, Gambetti S, Dondi A, Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr. Pharm. Des.10, 1611–1626 (2004).
   PubMed Web of Science ®Google Scholar
• Cui Y, Xu X, Bi H et al. Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. Exp. Eye Res.4, 807–816 (2006).
   Google Scholar
• Ferreira FM, Palmeira CM, Seica R, Moreno AJ, Santos MS. Diabetes and mitochondrial bioenergetics: alterations with age. J. Biochem. Mol. Toxicol.17, 214–222 (2003).
   PubMed Web of Science ®Google Scholar
• Duchen M. Roles of mitochondria in health and disease. Diabetes53, S96–S102 (2004).
   PubMed Web of Science ®Google Scholar
• Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med.350, 664–671 (2004).
   PubMed Web of Science ®Google Scholar
• Stauble B, Boscoboinik D, Tasinato A, Azzi A. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-α-tocopherol in vascular smooth muscles. Eur. J. Biochem.226, 393–402 (1994).
   PubMedGoogle Scholar
• Koya D, King G. Protein kinase C activation and the development of diabetic complications. Diabetes47, 859–866 (1998).
   PubMed Web of Science ®Google Scholar
• Maassen JA, ‘t Hart LM, Van Essen E et al. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes53, S103–S109 (2004).
   PubMed Web of Science ®Google Scholar
• Du X, Matsumura T, Edelstein D et al. Inhibition of GAPDH activity by poly(ADPribose) polymerase activates three major pathways of hyperglycemic damage in 5 endothelial cells. J. Clin. Invest.112, 1049–1057 (2003).
   PubMed Web of Science ®Google Scholar
• Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes54, 1615–1625 (2005).
   PubMed Web of Science ®Google Scholar
• Suzuki S, Hinokio Y, Komatu K et al. Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res. Clin. Pract.45, 161–168 (1999).
   PubMed Web of Science ®Google Scholar
• Kakimoto M, Inoguchi T, Sonta T et al. Accumulation of 8-hydroxy-2´-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes51, 1588–1595 (2002).
   PubMed Web of Science ®Google Scholar
• Maassen JA, Janssen GM, ‘t Hart LM. Molecular mechanisms of mitochondrial diabetes (MIDD). Ann. Med.37, 213–221 (2005).
   PubMed Web of Science ®Google Scholar
• Vincent AM, Olzmann JA, Brownlee M, Sivitz WI, Russell W. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes53, 726–734 (2004).
   PubMed Web of Science ®Google Scholar
• Brownlee M. A radical explanation for glucose-induced β cell dysfunction. J. Clin. Invest.112, 1788–1790 (2003).
   PubMed Web of Science ®Google Scholar
• Grune T, Reinheckel T, Davies KJ. Degradation of oxidized proteins in mammalian cells. FASEB J.11, 526–534 (1997).
   PubMed Web of Science ®Google Scholar
• Turko IV, Li L, Aulak KS, Stuehr DJ, Chang JY, Murad F. Protein tyrosine nitration in the mitochondria from diabetic mouse heart. Implications to dysfunctional mitochondria in diabetes. J. Biol. Chem.278, 33972–33977 (2003).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Invest. Ophthalmol. Vis. Sci.44, 5327–5334 (2003).
   PubMed Web of Science ®Google Scholar
• Kowluru RA. Diabetic retinopathy: mitochondrial dysfunction and retinal capillary cell death. Antiox. Redox Signal.7, 1581–1587 (2005).
   PubMed Web of Science ®Google Scholar
• Maassen JA, van den Ouweland JM, t’ Hart LM, Lemkes HH. Maternally inherited diabetes and deafness: a diabetic subtype associated with a mutation in mitochondrial 10 DNA. Horm. Metab. Res.29, 50–55 (1997).
   PubMed Web of Science ®Google Scholar
• Isashiki Y, Nakagawa M, Ohba N et al. Retinal manifestations in mitochondrial diseases associated with mitochondrial DNA mutation. Acta Ophthalmol. Scand.76, 6–13 (1998).
   PubMedGoogle Scholar
• Fukuda M, Nakano S, Imaizumi N et al. Mitochondrial DNA mutations are associated with both decreased insulin secretion and advanced microvascular complications in 15 Japanese diabetic subjects. J. Diabetes Complications13, 277–283 (1999).
   PubMed Web of Science ®Google Scholar
• Suzuki S, Oka Y, Kadowaki T et al. Clinical features of diabetes mellitus with the mitochondrial DNA 3243 (A-G) mutation in Japanese: maternal inheritance and mitochondria-related complications. Diabetes Res. Clin. Pract.59, 207–217 (2003).
   PubMed Web of Science ®Google Scholar
• Holmes-Walker DJ, Mitchell P, Boyages SC. Does mitochondrial genome mutation in 20 subjects with maternally inherited diabetes and deafness decrease severity of diabetic retinopathy? Diabetic Med.15, 946–952 (1998).
   PubMed Web of Science ®Google Scholar
• Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes44, 1323–1327 (1995).
   PubMed Web of Science ®Google Scholar
• Droge W. Free radicals in the physiological control of cell function. Physiol. Rev.82, 47–95 (2002).
   PubMed Web of Science ®Google Scholar
• Hammes HP. Pathophysiological mechanisms of diabetic angiopathy. J. Diabetes Complications17, 16–19 (2003).
   PubMed Web of Science ®Google Scholar
• Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved 10 homolog, Bax, that accelerates programmed cell death. Cell74, 609–619 (1993).
   PubMed Web of Science ®Google Scholar
• Podesta F, Romeo G, Liu WH et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am. J. Pathol.156, 1025–1032 (2000).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Rad. Res.37, 1169–1180 (2003).
   PubMed Web of Science ®Google Scholar
• Anuradha CD, Kanno S, Hirano S. Oxidative damage to mitochondria is a preliminary step to caspase-3 activation in fluoride-induced apoptosis in HL-60 cells. Free Rad. Biol. Med.31, 367–373 (2001).
   PubMed Web of Science ®Google Scholar
• Phaneuf S, Leeuwenburgh C. Cytochrome c release from mitochondria in the aging heart: a possible mechanism for apoptosis with age. Am. J. Physiol. Regul. Integr. Comp. Physiol.282, R423–R430 (2002).
   PubMed Web of Science ®Google Scholar
• Alnemri ES. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J. Cell Biochem.64, 33–42 (1997).
   PubMed Web of Science ®Google Scholar
• Mohr S, Zech B, Lapetina EG, Brune B. Inhibition of caspase-3 by S-nitrosation and 5 oxidation caused by nitric oxide. Biochem. Biophys. Res. Commun.238, 387–391 (1997).
   PubMed Web of Science ®Google Scholar
• Kristal BS, Koopmans SJ, Jackson CT, Ikeno Y, Park BJ, Yu BP. Oxidant-mediated repression of mitochondrial transcription in diabetic rats. Free Rad. Biol. Med.22, 813–822 (1997).
   PubMed Web of Science ®Google Scholar
• Wolf BB, Schuler M, Echeverri F, Green DR. Caspase-3 is the primary activator of 10 apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspaseactivated DNase inactivation. J. Biol. Chem.274, 30651–30656 (1999).
   PubMed Web of Science ®Google Scholar
• Mohr S, Xi X, Tang J, Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes51, 1172–1179 (2002).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Chakrabarti S, Chen S. Re-institution of good metabolic control in diabetic rats on the activation of caspase-3 and nuclear transcriptional factor (NF-κB) in the retina. Acta. Diabetologica44, 194–199 (2004).
   Google Scholar
• Cregan SP, Dawson VL, Slack RS. Role of AIF in caspase-dependent and caspaseindependent cell death. Oncogene26, 2785–2796 (2004).
   Google Scholar
• Packer L, Witt EH, Tritschler HJ. α-Lipoic acid as a biological antioxidant. Free Rad. Biol. Med.19, 227–250 (1995).
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Atasi L, Ho YS. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci.47, 1594–1599 (2006).
   PubMed Web of Science ®Google Scholar
• Lin J, Bierhaus A, Bugert P et al. Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy. Diabetologia49, 1089–1096 (2006).
   PubMed Web of Science ®Google Scholar
• Obrosova IG, Fathallah L, Greene DA. Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-α-lipoic acid. Eur. J. Pharmacol.398, 139–146 (2000).
   PubMed Web of Science ®Google Scholar
• Obrosova IG, Fathallah L, Liu E, Nourooz-Zadeh J. Early oxidative stress in the diabetic kidney: effect of DL-[α]-lipoic acid. Free Rad. Biol. Med.34, 186–195 (2003).
   PubMed Web of Science ®Google Scholar
• Sabu MC, Smitha K, Ramadasan K. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J. Ethnopharmacol.83, 109–116 (2002).
   PubMed Web of Science ®Google Scholar
• Mustata GT, Rosca M, Biemel KM et al. Paradoxical effects of green tea (Camellia sinensis) and antioxidant vitamins in diabetic rats: improved retinopathy and renal mitochondrial defects but deterioration of collagen matrix glycoxidation and cross-linking. Diabetes54, 517–526 (2005).
   PubMed Web of Science ®Google Scholar
• Mayer-Davis EJ, Bell RA, Reboussin BA, Rushing J, Marshall JA, Hamman RF. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Vally diabetes study. Ophthalmology105, 226–2270 (1998).
   Google Scholar
• Hammes HP, Du X, Edelstein D et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med.9, 294–299 (2003).
   PubMed Web of Science ®Google Scholar
• Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU, Mohan V. Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. J. Biosci.28, 715–721 (2003).
   PubMed Web of Science ®Google Scholar
• Suzuki S, Hinokio Y, Ohtomo M et al. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia41, 584–588 (1998).
   PubMed Web of Science ®Google Scholar
• Rauscher FM, Sanders RA, Watkins JB III. Effects of coenzyme Q10 treatment on antioxidant pathways in normal and streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol.15, 41–46 (2001).
   PubMed Web of Science ®Google Scholar
• Littarru GP, Tiano L. Clinical aspects of coenzyme Q10: an update. Curr. Opin. Clin. Nutr. Metab. Care8, 641–646 (2005).
   PubMed Web of Science ®Google Scholar
• Chida M, Suzuki K, Nakanishi-Ueda T et al. In vitro testing of antioxidants and biochemical end-points in bovine retinal tissue. Ophthalmic. Res.31, 407–415 (1999).
   PubMed Web of Science ®Google Scholar
• Frei B, Kim MC, Ames BN. Ubiquinol-10 is an effective lipid-soluble antioxidant at 15 physiological concentrations. Proc. Natl Acad. Sci. USA87, 4879–4883 (1990).
   PubMed Web of Science ®Google Scholar
• Sheu SS, Nauduri D, Anders MW. Targeting antioxidants to mitochondria: a new therapeutic direction. Biochim. Biophys. Acta1762, 256–265 (2006).
   PubMed Web of Science ®Google Scholar
• Smith RA, Porteous CM, Coulter CV, Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur. J. Biochem.263, 709–716 (1999).
   PubMedGoogle Scholar
• Dhanasekaran A, Kotamraju S, Kalivendi SV et al. Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J. Biol. Chem.279, 37575–37587 (2004).
   PubMed Web of Science ®Google Scholar
• Kelso GF, Porteous CM, Coulter CV et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem.276, 4588–4596 (2001).
   PubMed Web of Science ®Google Scholar
• Adlam VJ, Harrison JC, Porteous CM et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J.19, 1088–1095 (2005).
   PubMed Web of Science ®Google Scholar
• Filipovska A, Kelso GF, Brown SE, Beer SM, Smith RA, Murphy MP. Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria. J. Biol. Chem.280, 24113–24126 (2005).
   PubMed Web of Science ®Google Scholar
• Szeto HH. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. Am. Assoc. Pharm. Scient.8, E521–E531 (2006).
   Google Scholar
• Nassar T, Kadery B, Lotan C, Da’as N, Kleinman Y, Haj-Yehia A. Effects of the superoxide dismutase-mimetic compound Tempol on endothelial dysfunction in streptozotocin-induced diabetic rats. Eur. J. Pharmacol.436, 111–118 (2002).
   PubMed Web of Science ®Google Scholar
• Coppey LJ, Gellett JS, Davidson EP et al. Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Br. J. Pharmacol.134, 21–29 (2001).
   PubMed Web of Science ®Google Scholar
• Cuzzocrea S, Mazzon E, Dugo L et al. Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion. Br. J. Pharmacol.132, 19–29 (2001).
   PubMed Web of Science ®Google Scholar
• Salvemini D, Riley DP, Lennon PJ et al. Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage. Br. J. Pharmacol.127, 685–692 (1999).
   PubMed Web of Science ®Google Scholar
• Sharpe MA, Ollosson R, Stewart VC, Clark JB. Oxidation of nitric oxide by oxomanganese-salen complexes: a new mechanism for cellular protection by superoxide dismutase/catalase mimetics. Biochem. J.366, 97–107 (2002).
   PubMed Web of Science ®Google Scholar